CD4 and cancer: Deconvolution of bulk RNA sequencing (RNA-seq) data reveals high content at baseline in cancer cells, immunosuppressive cancer-associated fibroblasts, FOXP3+ CD4<sup>+</sup> regulatory T lymphocytes, and TREM2+ macrophages.